Inogen, Inc. (Nasdaq: INGN)


A class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of all persons or entities that purchased the common stock of Inogen, Inc. ("Inogen" or the "Company") (NASDAQ GS: INGN) between November 12, 2014 and March 11, 2015, inclusive (the "Class Period"), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the "Complaint").

The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements, and omitted materially adverse facts, about the Company's business, operations and prospects. As a result of defendants' alleged false and misleading statements, the Company's stock traded at artificially inflated prices during the Class Period.

According to the Complaint, on March 11, 2015, after the close of trading, the Company announced that management discovered potential accounting matters, which prompted an internal investigation conducted by the Audit Committee and independent advisors.

On this news, shares in Inogen dropped over 11%, closing at $33.10 per share on March 12, 2015, on heavy trading volume.

If you are a current shareholder and/or purchased stock between November 12, 2014 and March 11, 2015, and would like to discuss your options of exercising your rights as a shareholder, please contact us.

Please submit the following information so we can determine if you qualify for the suit. If you don't know all the specific details, partial information is also acceptable.

Personal Information
Name:
Phone #:
E-mail Address:
Stock Information
Do you currently own the stock? Yes   No
Purchase Date:
Quantity Purchased:
Purchase Price Per Share:

Please Note: Neither the submission to nor the receipt of information by The Law Offices of Marc S. Henzel or one of its attorneys through this website constitutes an agreement by the firm to represent the individual and does not create an attorney-client relationship.